Galapagos lands further in the red after spending spree
A highly-acquisitive and research-intensive year has left drug discovery services provider Galapagos further in the red at the end of its 2006 financial year, although sales soared.
A highly-acquisitive and research-intensive year has left drug discovery services provider Galapagos further in the red at the end of its 2006 financial year, although sales soared.
Agilent looks to maintain its strong market presence in the gas chromatography (GC) sector with the launch of two new instruments.